Lenvatinib mesylate
Lenvatinib mesylate | |
---|---|
Term | Lenvatinib mesylate |
Short definition | lenvatinib mesylate (len-VA-tih-nib MEH-zih-layt) A medicine used alone or with other medicines to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer) and thyroid cancer. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
lenvatinib mesylate - (pronounced) (len-VA-tih-nib MEH-zih-layt) A medicine used alone or with other medicines to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer) and thyroid cancer. It is also being studied in the treatment of other types of cancer. Lenvatinib mesylate blocks certain proteins that can help stop cancer cells from growing and kill them. It can also prevent the growth of new blood vessels that tumors need to grow. Lenvatinib mesylate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis drug. Also called lenvima
External links
- Medical encyclopedia article on Lenvatinib mesylate
- Wikipedia's article - Lenvatinib mesylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski